Efficacy and safety of insulin glargine 300 U/mL in people with T2D in China: the INITIATION study

被引：0
|
作者：
Chen, L. [1 ,2 ]
Wan, H. [3 ]
Han, J. [4 ]
Yang, C. [5 ]
Shao, H. [6 ]
Li, J. [7 ]
Yan, W. [8 ]
Zhang, M. [9 ]
Li, M. [10 ]
Han, Y. [10 ]
Kang, L. [10 ]
机构：
[1] Chu Hsien I Mem Hosp, Tianjin Key Lab Metab Dis, NHC Key Lab Hormones & Dev, Tianjin, Peoples R China
[2] Tianjin Med Univ, Tianjin Inst Endocrinol, Dept Endocrinol, Tianjin, Peoples R China
[3] Panjin Cent Hosp, Dept Endocrinol, Panjin, Peoples R China
[4] Hebei PetroChina Cent Hosp, Dept Endocrinol, Langfang, Peoples R China
[5] Guangzhou Med Univ, Affiliated Hosp 6, Qingyuan Peoples Hosp, Dept Endocrinol, Qingyuan, Peoples R China
[6] Nankai Univ, Tianjin Ctr Hosp 4, Dept Endocrinol, Tianjin, Peoples R China
[7] Ningbo Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Ningbo, Peoples R China
[8] Huadu Dist Peoples Hosp Guangzhou, Dept Endocrinol, Guangzhou, Peoples R China
[9] Sanofi Investment Co Ltd, Med RWE, Shanghai, Peoples R China
[10] Sanofi Investment Co Ltd, Med Diabet, Shanghai, Peoples R China
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2024年 / 209卷
关键词：
D O I：
10.1016/j.diabres.2024.111432
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
IDF23-0184
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naive People with Type 2 Diabetes: the ATOS Study
    Galstyan, Gagik R.
    Tirosh, Amir
    Vargas-Uricoechea, Hernando
    Mabunay, Maria Aileen
    Coudert, Mathieu
    Naqvi, Mubarak
    Pilorget, Valerie
    Khan, Niaz
    DIABETES THERAPY, 2022, 13 (06) : 1187 - 1202
  • [32] Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) in People with Type 2 Diabetes Mellitus (T2DM) Uncontrolled on Basal Insulins (BI): ARTEMIS-DM Study
    Sethi, Bipin
    Alrubeaan, Khalid
    Unubol, Mustafa
    Mabunay, Maria Aileen N.
    Naqvi, Mubarak
    Berthou, Baptiste
    Pilorget, Valerie
    Frechtel, Gustavo
    DIABETES, 2021, 70
  • [33] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Patients with T2D Uncontrolled on NPH or Premixed Insulins as Part of Routine Clinical Practice in Bulgaria: ToUPGRADE Study
    Kamenov, Zdravko
    Pehlivanova, Veselina
    Kuneva, Tsvetodara
    Kirilov, Kiril
    Bobeva, Roza
    Stoykova, Julija
    Mihalevska, Svetla
    DIABETES THERAPY, 2021, 12 (03) : 913 - 930
  • [34] The efficacy of switching from Insulin Glargine 100 U/mL (Gla-100) to Insulin Glargine 300 U/mL (Gla-300) in patients with type 2 diabetes mellitus
    Yang, K. -H.
    Tseng, C. -T.
    Chen, L. -C.
    Chen, P. -C.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 310 - 310
  • [35] Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis
    Nakanishi, Shuhei
    Iwamoto, Masahiro
    Kamei, Shinji
    Hirukawa, Hidenori
    Shimoda, Masashi
    Tatsumi, Fuminori
    Kohara, Kenji
    Obata, Atsushi
    Kimura, Tomohiko
    Kinoshita, Tomoe
    Irie, Shintaro
    Sanada, Junpei
    Fushimi, Yoshiro
    Nishioka, Momoyo
    Mizoguchi, Akiko
    Kameyama, Miyuki
    Mune, Tomoatsu
    Kaku, Kohei
    Kaneto, Hideaki
    INTERNAL MEDICINE, 2018, 57 (10) : 1381 - 1389
  • [36] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Patients with T2D Uncontrolled on NPH or Premixed Insulins as Part of Routine Clinical Practice in Bulgaria: ToUPGRADE Study
    Zdravko Kamenov
    Veselina Pehlivanova
    Tsvetodara Kuneva
    Kiril Kirilov
    Roza Bobeva
    Julija Stoykova
    Svetla Mihalevska
    Diabetes Therapy, 2021, 12 : 913 - 930
  • [37] REAL-WORLD EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML (GLA-300) IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES (T2DM): THE ATOS STUDY
    Galstyan, G.
    Tirosh, A.
    Vargas-Uricoechea, H.
    Mabunay, M.
    Quan, J.
    Pilorget, V.
    Cherkasov, D.
    Naqvi, M.
    Khan, N.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A23 - A23
  • [38] Real-Life Effectiveness of iGlarLixi (Insulin Glargine 100 U/ml and Lixisenatide) in People with Type 2 Diabetes (T2D) according to Prior Insulin Use
    Seufert, Jochen
    Freemantle, Nick
    Guja, Cristian
    Haluzik, Martin
    Bigot, Gregory
    Tournay, Mathilde
    Bonnemaire, Mireille
    Kis, Janos T.
    DIABETES, 2023, 72
  • [39] Efficacy and Safety of Insulin Glargine 300U/mL versus 100U/mL in Diabetes Mellitus: A Comprehensive Review of the Literature
    Vargas-Uricoechea, Hernando
    JOURNAL OF DIABETES RESEARCH, 2018, 2018
  • [40] Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching From Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)-DELIVER D plus Subgroup Analyses
    Sullivan, Sean D.
    Bailey, Timothy S.
    Roussel, Ronan
    Zhou, Fang L.
    Bosnyak, Zsolt
    Preblick, Ron
    Westerbacka, Jukka
    Gupta, Rishab
    Blonde, Lawrence
    DIABETES, 2018, 67
12345